Kyle Planck, who has recovered from a painful case of monkeypox, has joined advocacy groups and pleaded with elected officials to make the antiviral pills TPOXX more available. Yuki Iwamura/AFP via Getty Images hide caption
antiviral drugs
Merck says it will have 10 million packs of its new COVID-19 treatment available by the end of the month. Merck & Co., Inc. hide caption
Molnupiravir, an antiviral drug to treat mild to moderate COVID-19, is under consideration by the FDA for possible authorization. Merck hide caption
What A New Antiviral Drug Could Mean For The Future Of COVID
Molnupiravir, an antiviral drug to treat mild to moderate COVID-19, is under consideration by the FDA for possible authorization. Merck hide caption